VIVE — Viveve Medical Share Price
Last trade - 00:00- $0.00m
- -$0.28m
- $6.43m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0 | ||
| Price to Tang. Book | 0 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -1639.86% | ||
| Return on Equity | -261.13% | ||
| Operating Margin | -316.39% | ||
Financial Summary
| Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 15.29 | 18.52 | 6.57 | 5.48 | 6.43 | n/a | n/a | -2.09% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Viveve Medical, Inc. designs, develops, manufactures and markets a platform medical technology, Cryogen-cooled Monopolar RadioFrequency (CMRF). The Company’s CMRF technology is delivered through a radiofrequency generator, handpiece and treatment tip, which collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI). In the United States, the Viveve System is indicated for use in general surgical procedures for electrocoagulation and hemostasis. The Viveve System is cleared for marketing in approximately 48 countries throughout the world, including North America, Asia Pacific, Europe, the Middle East and Latin America countries. The Company’s wholly owned subsidiaries include Viveve, Inc. and Viveve BV.
Directors
- Steven Basta NEC (54)
- Scott Durbin CEO (52)
- Jim Robbins SVP (57)
- Deborah Jorn DRC (63)
- Arlene Morris IND (69)
- Sharon Presnell IND (52)
- Last Annual
- December 31st, 2021
- Last Interim
- September 30th, 2022
- Incorporated
- May 10th, 2016
- Public Since
- March 3rd, 1992
- No. of Shareholders
- 92
- No. of Employees
- 47
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 10,723,857
- Address
- 345 Inverness Drive South, ENGLEWOOD, 80112
- Web
- Phone
- +1 4085301900
- Auditors
- BPM LLP
Upcoming Events for VIVE
Similar to VIVE
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
Acutus Medical
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
FAQ
As of Today at 24:01 UTC, shares in Viveve Medical are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Viveve Medical last closed at $0.00 and the price had moved by -33.33% over the past 365 days. In terms of relative price strength the Viveve Medical share price has underperformed the S&P500 Index by -37.72% over the past year.
The overall consensus recommendation for Viveve Medical is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreViveve Medical does not currently pay a dividend.
Viveve Medical does not currently pay a dividend.
Viveve Medical does not currently pay a dividend.
To buy shares in Viveve Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Viveve Medical had a market capitalisation of $0.00m.
Here are the trading details for Viveve Medical:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: VIVE
Based on an overall assessment of its quality, value and momentum Viveve Medical is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Viveve Medical is $3.10. That is 1549900% above the last closing price of $0.00.
Analysts covering Viveve Medical currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Viveve Medical. Over the past six months, its share price has underperformed the S&P500 Index by -58.59%.
As of the last closing price of $0.00, shares in Viveve Medical were trading -27.81% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Viveve Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Viveve Medical's management team is headed by:
- Steven Basta - NEC
- Scott Durbin - CEO
- Jim Robbins - SVP
- Deborah Jorn - DRC
- Arlene Morris - IND
- Sharon Presnell - IND